Quick Answer
Regen BioPharma Inc reported Common Stock Shares Outstanding of 39.37 million shares for the year ending 2025.
- Regen BioPharma Inc showed an increase of +648.8% in Common Stock Shares Outstanding from 2024 to 2025.
- This data is from Regen BioPharma Inc's annual report (Form 10-K), filed with the SEC on December 30, 2025.
- XBRL data for this metric is available from 2013 to 2025 (13 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Over the full 13 years of available data (2013 to 2025), Regen BioPharma Inc's Common Stock Shares Outstanding has declined by 23.7%.
- Historical annual values: Fiscal year 2025: 39.37 million shares | Fiscal year 2024: 5.26 million shares | Fiscal year 2023: 3.51 million shares | Fiscal year 2022: 3.35 million shares | Fiscal year 2021: 4.35 billion shares | Fiscal year 2020: 1.61 billion shares | Fiscal year 2019: 180.32 million shares | Fiscal year 2018: 180.32 million shares | Fiscal year 2017: 139.70 million shares | Fiscal year 2016: 139.71 million shares | Fiscal year 2015: 114.75 million shares | Fiscal year 2014: 51.61 million shares | Fiscal year 2013: 51.61 million shares.
- Data sourced from SEC EDGAR public filings as of June 24, 2026.
Last verified: